DCF Advisers »

ImmunoGen shares owned by DCF Advisers

Quarter-by-quarter ownership of ImmunoGen shares owned by DCF Advisers from 13F filings

Historical chart of DCF Advisers investment in ImmunoGen

Tip: Access up to 7 years of quarterly data

All positions including ImmunoGen held by DCF Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ImmunoGen by DCF Advisers

Quarter filed Position value Share count Share price at filing
2023-09-30 $204k 13k 15.87
2023-06-30 $195k 10k 18.87

More positions owned by DCF Advisers

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Micron Technology (MU)
Argenx Se Sponsored Adr (ARGX)
Regeneron Pharmaceuticals (REGN)
Alphabet Cap Stk Cl C (GOOG)
Abbvie (ABBV)
Intra Cellular Therapies (ITCI)
Oracle Corporation (ORCL)
Spdr Gold Tr Gold Shs (GLD)
Energy Transfer Com Ut Ltd Ptn (ET)
Xencor (XNCR)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
Alibaba Group Hldg Sponsored Ads (BABA)
Prothena Corp SHS (PRTA)

View all positions for DCF Advisers

Top funds holding ImmunoGen

RA Capital Management
Redmile Group
Henderson Group
Pentwater Capital Management
Fairmount Funds Management
Norges Bank Investment Management
Millennium Management
D. E. Shaw & Co
Balyasny Asset Management
Voloridge Investment Management
Boxer Capital
Maverick Capital
TIG Advisors
Tang Capital Management
Wellington Management Company

View all funds holding ImmunoGen